Literature DB >> 12952846

Long-term survival after surgical treatment of patients with Takayasu's arteritis.

Tetsuro Miyata1, Osamu Sato, Hiroyuki Koyama, Hiroshi Shigematsu, Yusuke Tada.   

Abstract

BACKGROUND: Surgical interventions have been performed to ameliorate the complications of Takayasu's arteritis. However, the efficacy of surgery to increase long-term survival has not been established. METHODS AND
RESULTS: A retrospective review was performed on the survival of 106 consecutive patients with Takayasu's arteritis who underwent surgical treatment during the past 40 years. Their ages ranged from 5 to 69 years (mean+/-SEM, 31.7+/-1.3 years). Survival was compared with the reported results of medically treated patients according to Ishikawa's prognostic classification. There were 12 hospital deaths, and the remaining 94 patients were followed up from 8 months to 41.8 years (mean, 19.8 years). A serious long-term complication was anastomotic aneurysm, with a cumulative incidence at 20 years of 13.8%. Thirty-one late deaths were observed, and the major cause was congestive heart failure. The overall cumulative survival rate at 20 years was 73.5%. The prognostic classification by Ishikawa had little influence on the survival of surgically treated patients. For stage 3 patients, surgery seemed to increase survival; however, surgery-related complications conversely decreased the survival of stage 1 patients.
CONCLUSIONS: Surgery seems to increase the long-term survival of patients with stage 3 Takayasu's arteritis, whereas conservative treatment is recommended for those with stage 1 or 2 disease. An anastomotic aneurysm may occur at any time after surgery, and regular follow-up using imaging modalities such as multi-detector CT, MRI, or ultrasonography at least once every several years for the rest of the patient's life is mandatory for the early detection of anastomotic aneurysm.

Entities:  

Mesh:

Year:  2003        PMID: 12952846     DOI: 10.1161/01.CIR.0000089089.42153.5E

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Refractory rapidly progressive Takayasu's arteritis successfully treated with surgery.

Authors:  Ljiljana Petrovic-Rackov; Nada Pejnovic; Miodrag Jevtic
Journal:  Clin Rheumatol       Date:  2007-01-16       Impact factor: 2.980

Review 3.  Imaging studies in the diagnosis and management of vasculitis.

Authors:  Luis M Amezcua-Guerra; Carlos Pineda
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 4.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

Review 5.  Inflammatory and infectious aortic diseases.

Authors:  Amy R Deipolyi; Christopher D Czaplicki; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

6.  Longitudinal study of 16 patients with Takayasu's arteritis: clinical features and therapeutic management.

Authors:  Ljiljana Petrovic-Rackov; Nada Pejnovic; Miodrag Jevtic; Nemanja Damjanov
Journal:  Clin Rheumatol       Date:  2008-09-17       Impact factor: 2.980

7.  Anti-cytokine treatment for Takayasu arteritis: State of the art.

Authors:  Enrico Tombetti; Maria Chiara Di Chio; Silvia Sartorelli; Enrica Bozzolo; Maria Grazia Sabbadini; Angelo A Manfredi; Elena Baldissera
Journal:  Intractable Rare Dis Res       Date:  2014-02

8.  Takayasu arteritis: consideration of pulmonary involvement.

Authors:  Nobuyuki Nakajima
Journal:  Ann Vasc Dis       Date:  2008-10-17

Review 9.  Takayasu arteritis--advances in diagnosis and management.

Authors:  Justin C Mason
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

10.  Left main stem disease in a patient with Takayasu's arteritis.

Authors:  S Bulut; H M M Al Hashimi; F W A Verheugt
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.